Results 141 to 150 of about 19,811 (179)

Epidemiology and resistance mechanisms of tigecycline- and carbapenem-resistant <i>Enterobacteriaceae</i> in China: a multicentre genome-based study. [PDF]

Front Microbiol
Yan L, Ma T, Wang W, Cai Z, Du H, Chen Z, Han R, Guo Y, Li G, Jia W, Tao J.   +10 more
europepmc   +1 more source

Systematic Review and Meta-Analysis of Clinical Efficacy and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections. [PDF]

Int J Mol Sci
Bucataru A, Turcu-Stiolica A, Calina D, Balasoiu AT, Zlatian OM, Osman A, Balasoiu M, Ghenea AE.   +7 more
europepmc   +1 more source

Ceftazidime-avibactam versus polymyxins in treating patients with carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis. [PDF]

Infection
Chen J, Hu Q, Zhou P, Deng S.
europepmc   +1 more source